metricas
covid
Annals of Hepatology Implications of liver fibrosis in clinical trials
Journal Information

Statistics

Follow this link to access the full text of the article

Editorials
Implications of liver fibrosis in clinical trials
Vinay Jahagirdar, Kaanthi Rama
Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
Daniel Cabrera
Faculty of Medicine, Universidad de los Andes, Santiago 7620001, Chile
Centro de Estudios e Investigación en Salud y Sociedad, Escuela de Medicina, Facultad de Ciencias Médicas, Universidad Bernardo O Higgins, Santiago, Chile
Francisco Idalsoaga
Departamento De Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile
Division of Gastroenterology and Hepatology, Western University & London Health Sciences Centre, London, Canada
Luis Antonio Díaz
Departamento De Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile
MASLD Research Center, Division of Gastroenterology and Hepatology, University of California, San Diego, San Diego, CA, USA
Marco Arrese
Departamento De Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile
Juan Pablo Arab
Corresponding author
JuanPablo.Arab@vcuhealth.org

Corresponding author.
Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA
Departamento De Gastroenterología, Escuela De Medicina, Pontificia Universidad Católica De Chile, Santiago, Chile
Read
1452
Times
was read the article
837
Total PDF
615
Total HTML
Share statistics
Article information
ISSN: 16652681
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 84 132 216
2025 11 183 586 769
2025 10 200 81 281
2025 9 148 38 186

Follow this link to access the full text of the article